Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report, July – September 2017: IMPROVED GROSS MARGINS AND STRONG GROWTH IN THE DOMESTIC MARKET.

During the third quarter, Zinzino AB (publ.) has focused on profitability with balanced sales growth. Gross margins have significantly improved and EBITDA amounted to 5.8 MSEK for the quarter. Several new markets showed very good sales growth and the domestic market in Sweden continues to show strong growth.The third quarter has been characterized by good sales development of several new markets, alongside continued digitization and a focus on efficiency, logistics and deliveries. The biggest development has been in Germany, one of the world’s largest direct sales markets, which in Q3

Alfa Laval wins SEK 95 million natural gas order

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply evaporative air-cooler systems to a gas processing plant in the U.S. The order has a value of approximately SEK 95 million. It is booked in the Welded Heat Exchangers unit of the Energy Division, with deliveries scheduled for 2018.The Alfa Laval Niagara’s evaporative air-cooler systems will be used in two different steps of the process. They will be part of a refrigeration system to separate the natural gas into its individual pure component streams. They will also be part of

Moberg Pharma AB interim report January - September 2017

SUCCESS FOR NEW SKINNINE-MONTH PERIOD (JAN-SEPT 2017) · Net revenue SEK 348.9 million (244.9) · EBITDA SEK 62.4 million (65.9) · EBITDA excluding capital gains* SEK 49.4 million (24.7) · EBITDA for current product portfolio SEK 75.2 million(76.0) · Operating profit (EBIT) SEK 33.5 million (55.1) · Net profit after tax SEK 1.6 million (35.1) · Diluted earnings per share SEK 0.09 (2.45) · Operating cash flow per share SEK 1.40 (-1.64) THIRD QUARTER (JUL-SEPT 2017) · Net revenue SEK 108.3 million (104.1) · EBITDA SEK 36.0 million (29.0) · EBITDA

NCC to build swimming complex in Varberg

In cooperation with Varbergs Fastighets AB, NCC will design and build a new swimming complex in Varberg, Sweden. The assignment will be carried out as a partnering arrangement and comprise two phases. The total order value is expected to amount to approximately SEK 350 million.“Varberg is growing and this new swimming complex will be the municipality’s single largest investment to date. It will be designed to meet residents’ need for leisure, recreation and social activities,” says Ann-Charlotte Stenkil (Moderate Party), Chairman of the Municipal Executive Board. The investment also

Read original

Medals of War enters Open Beta on Android

Nitro Games, a leading Finnish developer and publisher of mobile games, announced it’s latest game “Medals of War” is now available on Android on the Google Play Store in Open Beta in 69 countries. “We’re now looking to introduce Medals of War to Android users, as well. There’s been a great demand for the Android version, so we wanted to open up the Google Play Open Beta in countries where the iOS version is already available. This gives the Android players the opportunity to play together with iOS players.” says Jussi Tähtinen, CEO & Co-Founder, Nitro Games Oyj. This launch

Bonava sells housing project with 36 rental apartments in Germany

Bonava has sold 36 rental apartments divided on several buildings and a commercial premise to the investor WERTGRUND. The project is located in Bonn.- Germany is a strategically important market for us, especially in terms of developing our rental business. This project clearly indicates our vision for developing homes and happy neighbourhoods where people have the highest quality of life. This time, it is in the form of high-quality, affordable rental units, says Joachim Hallengren, President and CEO of Bonava.  The rental apartments are part of a new residential area now taking form in

ROTTNEROS INTERIM REPORT JANUARY – SEPTEMBER 2017

INCREASE IN PRODUCTION ACCORDING TO PLAN, RECORD QUARTER AT VALLVIK · Production volume in the third quarter rose by 12% to 102.5 thousand tonnes (91.9). Vallvik Mill set a new quarterly production record. Rottneros Mill underwent its annual maintenance shutdown in September. · Investments in the Agenda 500 development programme are progressing according to plan, in terms of both costs and increased capacity. The new biofuel boiler makes Rottneros Mill’s energy consumption essentially fossil-free. · Financing of the Agenda 500 programme has been secured with a 5-year bond issue

TECHSTEP LANSERER MYTOS I SVERIGE

Techstep ASA lanserer nå tjenestene til Mytos i det svenske markedet. Målet er å forsterke sin posisjon innen Mobile as a Service (MaaS), og tilby nordiske kunder en enklere og mer mobil arbeidsdag. Mytos har befestet sitt grep i det norske Telecom Expense Management (TEM) markedet med over 150.000 brukere i offentlig og privat sektor. Nå lanserer morselskapet Techstep ASA løsningen i det svenske markedet, og forsterker med dette sin tjenesteportefølje i nabolandet. Nordisk etterspørselSatsingen kommer som et resultat av stor etterspørsel i det svenske markedet og fra nordiske

Phase II-trial DIAGNODE-2 ahead of World Diabetes Day now open to include patients

Diamyd Medical's pivotal trial DIAGNODE-2 is now open for booking patients. The diabetes vaccine Diamyd® for intralymphatic administration will be delivered to the clinics participating in the trial that can begin screening patients. DIAGNODE-2 comprises about 80 patients from Spain, the Czech Republic and Sweden between the ages of 12-24 who have been diagnosed with type 1 diabetes in the last 6 months.“Given the highly promising data we have seen from DIAGNODE-1, it is of course a great event and a potential opportunity for diabetes patients, and we are particularly pleased that we can

Oncology-focused Ascelia Pharma strengthens its board of directors to support international expansion

Malmö-based Ascelia Pharma, a specialty pharmaceutical company dedicated to the development of novel medicines to improve the life expectancy and quality of life for people living with cancer, is strengthening its current board of directors with the addition of Helena Wennerström and Hans Maier as the company prepares to continue its growth journey.”With our two strong drug candidates – Mangoral® and Oncoral – we are ready to take Ascelia Pharma to the next level. We are very pleased that Helena Wennerström and Hans Maier will be joining the board and sharing their valuable expertise and

Detsky Mir, MedLife, Canvest Environmental Protection Group and Globant recognised at the 14th annual East Capital Awards

East Capital, a specialist asset manager in emerging and frontier markets, today announces the winners of the 2017 East Capital Awards: ·  Detsky Mir               Best Growth Award ·  MedLife                    Best IPO Award ·  Canvest                    Discovery of the Year Award ·  Globant                    Best Corporate Governance This is the 14th year that the East Capital Awards honour remarkable companies in East Capital’s investment universe. Peter Elam Håkansson, Chairman and CIO of East Capital, said: “The Awards serve to highlight some of the most outstanding

KappAhl estimates lower sales during the first quarter

KappAhl AB (publ.) estimates that their operating profit for the first quarter 2017/2018 will be lower than the first quarter 2016/2017.        – Sales during the quarter has not lived up to our expectations so far. This is mainly depending on our price- and campaign strategy that has not given the effect we wished for in the tough market climate during the fall, says KappAhl’s President and CEO Danny Feltmann.KappAhl estimates that the operating profit for the first quarter 2017/2018 will be approximately 100 MSEK, compared to 145 MSEK for the first quarter 2016/2017. Sales during the

New study backs up earlier findings – omega-6 fatty acids do not promote low-grade inflammation

The higher the serum linoleic acid level, the lower the CRP, according to a new study from the University of Eastern Finland. Linoleic acid is the most common polyunsaturated omega-6 fatty acid. The findings were published in the European Journal of Clinical Nutrition. It has been speculated that a high intake of omega-6 polyunsaturated fatty acids may increase the risk of several chronic diseases by promoting low-grade inflammation, among other things. The reasoning behind this speculation is that in the human body, linoleic acid is converted into arachidonic acid (also an omega-6 fatty

Kungsleden rents out 5 800 sq.m at Gärdet Frihamnen

Kungsleden has signed a lease agreement of 5 400 square meter with HD Resources in the Rotterdam 1 property and a lease agreement of 400 square meter with InfoZone in the Tegeludden 13 property. The properties are located in Kungsleden's cluster Stockholm City Öst, in the expansive area at Gärdet / Frihamnen.Kungsleden owns four office buildings with a total of 89 000 square meter in the Stockholm City Öst cluster at Gärdet / Frihamnen. The area, Norra Djurgårdsstaden, is part of Stockholm's largest urban development area. Gärdet / Frihamnen has a very attractive location close to both

Multiconsult ASA – Repurchase of own shares

On 10 November 2017, Multiconsult ASA ("Multiconsult") purchased 4 000 of its own shares at an average price of NOK 81.48 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 127 528 of its own shares.  For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

AMERICANS ARE PRO-CONNECTIVITY, EVEN IN ONE OF THE FEW PLACES LEFT TO POWER DOWN

Allianz Global Assistance Discovers That Americans Want Free In-Flight Texting, Wi-Fi and Cellular Calls, but Don’t Want their Fellow Passengers to Use itThose who thought that airplanes might remain a haven from emails, text messages and phone calls may want to think again. The majority of Americans would use free Wi-Fi (76.2 percent) and cellular calls (55.5 percent), and nearly half (44.7 percent) would use free text messaging services if provided on a flight, according to a new survey* conducted by leading travel insurance provider Allianz Global Assistance 

Philanthropists Frank & Margarita Leon Host 4th Annual “Evening of Hope” on Sunday, November 19, 2017 at LaLoggia Restaurant

-- 100% of proceeds will provide critically needed spinal surgeries for some of the world's most disadvantaged children at the FOCOS Orthopedic Hospital in Ghana --WHO: Restaurateur Frank Leon and his attorney wife Margarita Manduley are hosting their Fourth Annual Evening of Hope charity benefit to help pediatric patients in critical need of life-altering spinal surgeries at the FOCOS (The Foundation of Orthopedics and Complex Spine) Orthopedic Hospital in Ghana. The world’s leading pediatric orthopedic surgeon and FOCOS founder, Dr. Oheneba Boachie , will

Invitation to Capital Market Day 2017 with TargetEveryones

TargetEveryone hereby invites analytics, investors and media to our Capital Market Day in Oslo at November 22, 2017. The purpose with the Capital Market Day is to present an updated strategy and financial goals of TargetEveryone. Key speaker will be the CEO of TargetEveryone, Bjorn Forslund, and other prominent guests from the business. Place: Hoyres Hus, Stortingsgaten 20, Oslo Day and time: Wednesday November 22 at 08.00 a.m. CET Please register no later than Tuesday, 21 November 2017. For a complete program and registering please contact Jan Benjaminson; jan@targeteveryone.

DNB ASA - Share buy-back:Transactions during week 45

During week 45 2017, DNB ASA has purchased 910,000 own shares at an average price of NOK 159.06 per share. During this programme DNB ASA has bought 2,995,034 own shares and now owns a total of 8,370,068 own shares. The repurchase of shares is part of the new share buy-back programme announced by DNB ASA on 21 September 2017. The buy-back programme comprises up to approximately 8.1 million shares, of which up to approximately 5.4 million will be repurchased in the open market. The rest will be redeemed from the state of Norway on a proportionate basis, subject to approval from DNB ASA’s

Successful digital mining project continues

By using the latest mobile network technology, Swedish companies, universities and research institutes have collaborated to make it possible to remote control and automate activities in the mine. The project will now continue with the objective to enable mining operators, maintenance personnel, equipment and machines from different suppliers to be connected and share data. That will create increased safety and productivity in the mine. An innovative way of thinking that enables new services that also can be used in other industries. The participating partners in PIMM DMA, the Digitalized

Announcement of managers' transactions: Grevermond Investments Ltd has purchased shares in Caverion Corporation on November 8, 2017

Caverion Corporation Stock exchange release November 10, 2017 at 5.00 p.m. EETAnnouncement of managers' transactions: Grevermond Investments Ltd has purchased shares in Caverion Corporation on November 8, 2017 Person subject to the notification requirement Name: Grevermond Investments Ltd Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Rosenlew Michael Position: Member of the Board Issuer: Caverion Oyj LEI: 7437007ECQWVPCJIS695 Notification type: INITIAL NOTIFICATION Reference number:

Goldenberg Dermatology first in the US to offer SciBase’s Nevisense screening for early detection of melanoma

November 9th SciBase announced that the Company had received the first order in the US from Goldenberg Dermatology, a premier New York City dermatology practice of Dr. Gary Goldenberg and Dr. Kristina Goldenberg. The order, consisting of a Nevisense system and single-use electrodes, means that Drs. Goldenberg will be the first dermatologists in the US to be able to offer the Nevisense test for early detection of melanoma and atypical moles (nevi). Earlier this fall, at the Fall Clinical Dermatology Conference SciBase was mentioned as one of the ten most important new technologies within skin

Karessa Pharma AB presents at Stora Aktiedagen the 13th of  November 2017

Michael Brobjer, CEO at Karessa Pharma AB will present the company's latest development and updates at Stora aktiedagen at Sheraton in Stockholm on Monday the 13thof November. The presentation will be live streamed and can be followed at http://www.aktiespararna.se/tv/live. About Karessa's pharmaceutical projects for treatment of erectile dysfunctionCurrent treatment of impotence is well proven and has a favorable safety profile, but many patients are bothered by the delayed onset and that it may vary depending on food intake. These problems are a consequence of the drug being given as

There are no items matching the current filter
There are no more items matching the current filter
Back to top